Ann Conkle
Apr 16, 2012
Merck outlines $1 Billion deal for ovarian cancer drug
Merck will pay $120 million upfront, with additional payments of up to $880 million if future milestones are reached.
Merck will pay $120 million upfront, with additional payments of up to $880 million if future milestones are reached.